stockrow
Saturday 7 November 2026
Export EDVA’s income statement to Excel — free account
Splash Beverage Group, Inc.
EDVA Healthcare Biotechnology
Splash Beverage Group, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $73,100.00, down 98.2% from fiscal 2024.
- Revenue
- −99.6%
- EPS
- +95.6%
- Free cash flow
- −95.7%
- Total debt
- −100.0%
Quarter to June 2026, against a year earlier
0.19
0.02
+11.76%
Follow EDVA
Alert me
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
Piotroski F-Score |
+8 more TTM periods Free account |
— | 3 | 2 | — |
| 1,534.01% | 153.62% | 137.61% | 525.95% | ||
| (201.40%) | (1,399.60%) | (1,520.61%) | (158.63%) | ||
ROIC |
(123.62%) | 0.00% | 0.00% | 0.00% | |
Return on Tangible Assets |
228.84% | 166.93% | 153.38% | 116.11% | |
Average Days of Receivables |
0.00 | 24.25 | 52.89 | 0.00 | |
Free Cash Flow per Share |
(8.67) | (8.85) | (4.33) | (1.79) | |
Free Cash Flow |
(4.75) | (4.82) | (4.94) | (5.47) | |
Capital Expenditures |
— | — | — | 0.01 | |
| Other line items | |||||
Cash ROIC |
(66.87%) | 32.10% | 31.24% | 35.30% | |
Accounts Receivable Turnover |
0.00 | 6.13 | 2.71 | 0.00 | |
Accounts Payable Turnover |
0.00 | (0.29) | (0.35) | 0.00 | |
Inventory Turnover |
0.00 | (6.82) | (4.13) | 0.00 | |
Average Days of Payables |
0.00 | (1,460.39) | (894.00) | 0.00 | |
Days of Inventory on Hand |
0.00 | (10.17) | (10.60) | 0.00 | |
Tax Rate |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
— | 0.00% | 0.00% | — | |
Selling, General and Administrative Expense of Revenue |
0.00% | 819.23% | 1,953.14% | 0.00% | |
Share Based Compensation of Revenue |
0.00% | 518.68% | 1,288.79% | 0.00% | |
Interest Coverage |
(4.01) | (5.62) | (4.87) | (5.88) | |
Operating CF/Net income |
0.15 | 0.18 | 0.20 | 0.30 | |
Depreciation/Fixed assets |
29.20 | 188.79 | 138.38 | (2,658.33) | |
Capex/Depreciation |
0.00 | 0.00 | 0.00 | 0.01 | |
Revenue per Share |
0.00 | 3.01 | 0.58 | 0.00 | |
Operating CF per Share |
(8.67) | (8.85) | (4.33) | (1.79) | |
Capex per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Capex to Sales |
— | 0.00 | 0.00 | 0.00 |
Columns are period end dates · fundamentals updated 26 Oct 2026